COVID-19 Coinfection With Mucormycosis in a Diabetic Patient

  • R R
  • Thanthoni M
  • Warrier A
N/ACitations
Citations of this article
51Readers
Mendeley users who have this article in their library.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a form of β-Coronavirus of the Coronaviridae family, has been causing infection among humans worldwide leading to a pandemic emergency. New strains of SARS-CoV-2 have been evolving unceasingly, presenting with various systemic and oral manifestations. There has been an increase in the incidence of secondary infection in the coronavirus infected individual either due to pre-existing factors or the virus by itself is causing such infection, which is still unclear. As it is already known, immunocompromised and uncontrolled diabetic patients have an increased chance of developing mucormycosis. Herein, we report a case who presented with a swelling in the left cheek, eye, and avascular necrosis intraorally, post COVID-19 infection.

Cite

CITATION STYLE

APA

R, R., Thanthoni, M., & Warrier, A. S. (2021). COVID-19 Coinfection With Mucormycosis in a Diabetic Patient. Cureus. https://doi.org/10.7759/cureus.15820

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free